| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-12 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |